DK1581504T3 - Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden - Google Patents

Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden

Info

Publication number
DK1581504T3
DK1581504T3 DK04700707T DK04700707T DK1581504T3 DK 1581504 T3 DK1581504 T3 DK 1581504T3 DK 04700707 T DK04700707 T DK 04700707T DK 04700707 T DK04700707 T DK 04700707T DK 1581504 T3 DK1581504 T3 DK 1581504T3
Authority
DK
Denmark
Prior art keywords
sub
imidazole derivatives
substituted imidazole
preparing substituted
intermediates used
Prior art date
Application number
DK04700707T
Other languages
Danish (da)
English (en)
Inventor
Paeivi Juujaervi
Seppo Parhi
Jaana Karjalainen
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Application granted granted Critical
Publication of DK1581504T3 publication Critical patent/DK1581504T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK04700707T 2003-01-08 2004-01-08 Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden DK1581504T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030026A FI116292B (fi) 2003-01-08 2003-01-08 Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
PCT/FI2004/000004 WO2004063168A1 (en) 2003-01-08 2004-01-08 Process for preparing substituted imidazole derivatives and intermediates used in the process

Publications (1)

Publication Number Publication Date
DK1581504T3 true DK1581504T3 (da) 2009-06-29

Family

ID=8565279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04700707T DK1581504T3 (da) 2003-01-08 2004-01-08 Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden

Country Status (21)

Country Link
US (1) US7223871B2 (de)
EP (1) EP1581504B1 (de)
JP (1) JP4592680B2 (de)
KR (1) KR101079065B1 (de)
CN (1) CN100339368C (de)
AT (1) ATE425972T1 (de)
AU (1) AU2004203941B2 (de)
BR (1) BRPI0406676A (de)
CA (1) CA2511969C (de)
DE (1) DE602004020050D1 (de)
DK (1) DK1581504T3 (de)
ES (1) ES2322463T3 (de)
FI (1) FI116292B (de)
IL (1) IL168452A (de)
MX (1) MXPA05007217A (de)
NO (1) NO330965B1 (de)
NZ (1) NZ539831A (de)
PL (1) PL213564B1 (de)
PT (1) PT1581504E (de)
RU (1) RU2329253C2 (de)
WO (1) WO2004063168A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2456749B1 (de) * 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Indanderivate zur verwendung als zwischenprodukte
EP2459540A4 (de) * 2009-07-31 2012-12-19 Reddys Lab Ltd Dr Herstellung von fipamezol
EP2502917A1 (de) * 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Im Festzustand kristalline Formen von 4-(2-Ethyl-5-fluor-2,3-dihydro-1H-inden-2-yl)-1H-imidazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
AU7040500A (en) 1999-09-06 2001-04-10 Lg Chem Investment Ltd. Process for preparing a 1-substituted 5-hydroxymethyl imidazole
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Also Published As

Publication number Publication date
AU2004203941A1 (en) 2004-07-29
KR101079065B1 (ko) 2011-11-02
EP1581504B1 (de) 2009-03-18
US20060025465A1 (en) 2006-02-02
RU2005125044A (ru) 2006-01-20
NO20053712L (no) 2005-08-01
PL378179A1 (pl) 2006-03-06
JP4592680B2 (ja) 2010-12-01
FI20030026A (fi) 2004-07-09
JP2006515349A (ja) 2006-05-25
CA2511969C (en) 2011-10-11
CN100339368C (zh) 2007-09-26
FI116292B (fi) 2005-10-31
BRPI0406676A (pt) 2005-12-20
PT1581504E (pt) 2009-05-26
MXPA05007217A (es) 2005-09-12
CA2511969A1 (en) 2004-07-29
EP1581504A1 (de) 2005-10-05
AU2004203941B2 (en) 2009-08-06
US7223871B2 (en) 2007-05-29
ATE425972T1 (de) 2009-04-15
IL168452A (en) 2009-07-20
PL213564B1 (pl) 2013-03-29
RU2329253C2 (ru) 2008-07-20
FI20030026A0 (fi) 2003-01-08
CN1723202A (zh) 2006-01-18
KR20050091065A (ko) 2005-09-14
NZ539831A (en) 2007-11-30
WO2004063168A1 (en) 2004-07-29
DE602004020050D1 (de) 2009-04-30
ES2322463T3 (es) 2009-06-22
NO330965B1 (no) 2011-08-29

Similar Documents

Publication Publication Date Title
HK1167658A1 (en) Composition for the preparation of 17-vinyl- triflates as intermediates 17--
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
EA201070437A2 (ru) Способ получения 2'-дезокси -5-азацитидина (децитабина)
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
DK1246812T3 (da) Fremgangsmåde til fremstilling af citalopram
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
EA200700767A1 (ru) Способ получения пиразолов
ATE428693T1 (de) Prostaglandinsynthese
MEP18708A (en) Process for the production of beraprost and its salts
DK1489080T3 (da) Fremgangsmåde til frembringelse af cilostazol
RS20060157A (en) Method for the manufacture of thip
MXPA03011647A (es) Procedimiento de resolucion para el acido ( r ) - (-) - 2-hidroxi - 2- (2 - clorofenil) acetico.
IS6636A (is) Hringlaga ketonar og notkun þeirra í smíði amínósýra
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
DK1631533T3 (da) Hidtil ukendt fremgangsmåde til stereoselektiv reduktion af beta-ketoestre
EA200501135A1 (ru) Способы получения алкалоидов хиназолина
DK1296965T3 (da) Fremgangsmåde til fremstilling af 4-brom-anilinderivater
DK1575902T3 (da) Skadedyrsfrastødende sammensætninger og forbindelser
DK1392652T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
NO20055925L (no) Ny fremgangsmate for fremstilling av melagatran